PER 0.64% 7.8¢ percheron therapeutics limited

Pfizer takeover of CD47 blocking Co.

  1. 300 Posts.
    lightbulb Created with Sketch. 833
    Pfizer has just bought Trillium Therapeutics (TRIL.NAS)… for U$2.2bn (AUD$3.1bn)… PFE are paying $18.50/shr. Trillium was trading at 28c in November 2019…

    Importantly, TRIL targets CD47.. they are currently in P1b/2 across several indications

    ”DEVELOPING NOVEL IMMUNOTHERAPIES FOR CANCER WITH A FOCUS ON CD47 BLOCKADE”

    https://trilliumtherapeutics.com
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.8¢
Change
-0.001(0.64%)
Mkt cap ! $71.22M
Open High Low Value Volume
7.8¢ 7.9¢ 7.8¢ $1.882K 24.11K

Buyers (Bids)

No. Vol. Price($)
1 6454 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 125752 3
View Market Depth
Last trade - 13.43pm 23/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.